Giuseppe Guglielmi
Overview
Explore the profile of Giuseppe Guglielmi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
324
Citations
3364
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Balbino M, Masino F, Montatore M, Carpagnano F, Guglielmi G
Radiol Case Rep
. 2025 Feb;
20(4):2148-2152.
PMID: 39975646
Ovarian tumors represent a significant health concern for women, often leading to morbidity and mortality. We present the case of a 46-year-old patient without notable personal or family history of...
2.
Columbu C, Rendina D, Gennari L, Pugliese F, Carnevale V, Salcuni A, et al.
Endocrine
. 2025 Feb;
PMID: 39934509
Purpose: Parathyroid hormone controls calcium and phosphate metabolism. The latter is also regulated by both FGF23 and 1-25(OH)VitaminD. The polymorphic variant c.716 C > T of the FGF23 gene was...
3.
Ju Z, Leng X, Xiao B, Sun M, Huang H, Hu G, et al.
Quant Imaging Med Surg
. 2025 Jan;
15(1):74-87.
PMID: 39838988
Background: Magnetic resonance (MR) diffusion-derived 'vessel density' (DDVD) is calculated according to: DDVD = Sb0/ROI - S/ROI, where S and S refer to the tissue signal when -value is 0...
4.
Bertoldo F, Eller-Vainicher C, Fusco V, Mauceri R, Pepe J, Bedogni A, et al.
J Bone Oncol
. 2025 Jan;
50():100656.
PMID: 39807373
Background: Low-doses of bone modifying agents (LD-BMAs) compared to those used to treat bone metastases are used in breast or prostate cancer patients on adjuvant endocrine therapy to prevent Cancer...
5.
DArma G, Balzano R, Masino F, Guglielmi G
Encephalitis
. 2024 Dec;
5(1):15-20.
PMID: 39668403
We describe the case of a 47-year-old woman who was confused and complained about left-sided weakness when she presented to our institution. The patient underwent a head computed tomography that...
6.
Guerra F, Palladino N, Winzenrieth R, Guglielmi G
J Diabetes Metab Disord
. 2024 Nov;
23(2):2191-2199.
PMID: 39610557
Objectives: Primary hyperparathyroidism (PHPT) is a disorder marked by chronic parathyroid hormone hypersecretion, which affects bone turnover and remodelling processes. With a loss of bone density and an increase in...
7.
Fusaro M, Aghi A, Marino C, Mallamaci F, Plebani M, Zaninotto M, et al.
J Clin Med
. 2024 Oct;
13(19).
PMID: 39407947
Chronic kidney disease and mineral bone disorders (CKD-MBD) are frequently associated with an increased risk of both vascular calcifications (VCs) and bone fractures (BFs). The complex pathogenesis of VCs and...
8.
Isaac A, Akdogan A, Dalili D, Saber N, Drobny D, Guglielmi G, et al.
Semin Musculoskelet Radiol
. 2024 Oct;
28(5):610-619.
PMID: 39406223
Artificial intelligence (AI) has significantly impacted the field of medical imaging, particularly in diagnosing and managing metabolic bone diseases (MBDs) such as osteoporosis and osteopenia, Paget's disease, osteomalacia, and rickets,...
9.
Gazzotti S, Sassi R, Aparisi Gomez M, Guglielmi R, Nikodinovska V, Messina C, et al.
Semin Musculoskelet Radiol
. 2024 Oct;
28(5):594-609.
PMID: 39406222
Body composition is now recognized to have a major impact on health and disease. Imaging enables its analysis in an objective and quantitative way through diverse techniques such as dual-energy...
10.
Cheng X, Wang L, Blake G, Guglielmi G
Semin Musculoskelet Radiol
. 2024 Oct;
28(5):557-559.
PMID: 39406219
Quantitative computed tomography (QCT) has important technical advantages for the measurement of bone mineral density, and the technique is well suited for both the diagnosis of osteoporosis and the monitoring...